TORL Biotherapeutics LLC — Form D

TORL Biotherapeutics LLC of Culver City, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-17. The offering totals $158.3M, of which $158.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-04-17
• Form: D
• Accession: 0001797180-24-000003
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $158.3M
• Amount sold: $158.3M
• Investors: 52
• Date of first sale: 2024-04-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-510814

Issuer

• Name: TORL Biotherapeutics LLC
• CIK: 0001797180
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Address: 6100 Bristol Parkway, Culver City, CA, 90230
• Phone: (424) 652-9370

Officers, directors & promoters (9)

More

• CIK 1797180 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search